Francesco Ceci
Francesco Ceci
Division of Nuclear Medicine, Department of Medical Sciences, University of Turin
Verified email at unito.it - Homepage
TitleCited byYear
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ...
European journal of nuclear medicine and molecular imaging 42 (8), 1284-1294, 2015
1992015
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
WP Fendler, M Eiber, M Beheshti, J Bomanji, F Ceci, S Cho, F Giesel, ...
European journal of nuclear medicine and molecular imaging 44 (6), 1014-1024, 2017
1692017
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
P Castellucci, F Ceci, T Graziani, R Schiavina, E Brunocilla, R Mazzarotto, ...
Journal of Nuclear Medicine 55 (9), 1424-1429, 2014
1002014
68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage …
J Calais, J Czernin, M Cao, AU Kishan, JV Hegde, N Shaverdian, ...
Journal of Nuclear Medicine 59 (2), 230-237, 2018
752018
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial
F Ceci, K Herrmann, P Castellucci, T Graziani, C Bluemel, R Schiavina, ...
European journal of nuclear medicine and molecular imaging 41 (12), 2222-2231, 2014
752014
11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT
F Ceci, P Castellucci, T Graziani, R Schiavina, E Brunocilla, R Mazzarotto, ...
European journal of nuclear medicine and molecular imaging 41 (5), 878-886, 2014
662014
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level< 0.5 ng/mL
M Mamede, F Ceci, P Castellucci, R Schiavina, C Fuccio, C Nanni, ...
Clinical nuclear medicine 38 (9), e342-e345, 2013
652013
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
F Ceci, P Castellucci, T Graziani, R Schiavina, R Renzi, M Borghesi, ...
European journal of nuclear medicine and molecular imaging 43 (1), 84-91, 2016
502016
11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
F Ceci, P Castellucci, M Mamede, R Schiavina, D Rubello, C Fuccio, ...
European journal of nuclear medicine and molecular imaging 40 (2), 149-155, 2013
492013
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
T Graziani, F Ceci, P Castellucci, G Polverari, GM Lima, F Lodi, ...
European journal of nuclear medicine and molecular imaging 43 (11), 1971-1979, 2016
452016
Comparison of 68Ga-PSMA-11 and 18F-fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
J Calais, WP Fendler, K Herrmann, M Eiber, F Ceci
Journal of Nuclear Medicine 59 (5), 789-794, 2018
392018
11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer
F Ceci, P Castellucci, T Graziani, R Schiavina, S Chondrogiannis, ...
Clinical nuclear medicine 40 (5), e265-e270, 2015
332015
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
S Fanti, S Minozzi, JJ Morigi, F Giesel, F Ceci, C Uprimny, MS Hofman, ...
European journal of nuclear medicine and molecular imaging 44 (10), 1622-1635, 2017
272017
Restaging clear cell renal carcinoma with 18F-FDG PET/CT
C Fuccio, F Ceci, P Castellucci, EG Spinapolice, R Palumbo, ...
Clinical nuclear medicine 39 (6), e320-e324, 2014
242014
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques
R Schiavina, F Ceci, M Borghesi, E Brunocilla, V Vagnoni, M Gacci, ...
Curr Radiopharm 6 (2), 92-5, 2013
242013
Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings
E Brunocilla, F Ceci, R Schiavina, P Castellucci, AM Maffione, M Cevenini, ...
Clinical nuclear medicine 39 (5), e308-e312, 2014
232014
Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings
E Brunocilla, F Ceci, R Schiavina, P Castellucci, AM Maffione, M Cevenini, ...
Clinical nuclear medicine 39 (5), e308-e312, 2014
232014
11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard
F Ceci, L Bianchi, T Graziani, P Castellucci, C Pultrone, B Eugenio, ...
Clinical nuclear medicine 40 (2), e124-e128, 2015
202015
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment …
A Farolfi, F Ceci, P Castellucci, T Graziani, G Siepe, A Lambertini, ...
European journal of nuclear medicine and molecular imaging 46 (1), 11-19, 2019
182019
New aspects of molecular imaging in prostate cancer
F Ceci, P Castellucci, JJ Cerci, S Fanti
Methods 130, 36-41, 2017
182017
The system can't perform the operation now. Try again later.
Articles 1–20